EXCELLENCE IMAGERIE acquired by METRIC CAPITAL PARTNERS

Dentalcorp Holdings Ltd. has successfully completed a statutory plan of arrangement to be acquired by an acquisition vehicle affiliated with GTCR. Under the terms of the agreement, GTCR acquired all issued and outstanding subordinate and multiple voting shares for C$11.00 per share in cash. The transaction represents a premium of approximately 33% over the 20,day volume weighted average trading price prior to the initial announcement in September 2025. Following the completion of the deal, the company is expected to be de,listed from the Toronto Stock Exchange and will cease to be a reporting issuer in Canada. As part of the strategic structure, the founder and senior executive leadership, alongside certain partner dentists, rolled a significant portion of their existing shares into the post,closing capital structure. This rollover ensures leadership continuity and aligns the interests of the management team with the new private ownership. The acquisition provides the organization with enhanced flexibility as a private entity to invest in technology, patient care infrastructure, and professional development. The transaction was unanimously recommended by a Special Committee of independent directors and the Board of Directors, following a comprehensive negotiation process designed to crystallize value for shareholders while supporting the group's long,term expansion.

Terveystalo signed an agreement to acquire Hohde Group, comprising Hammas Hohde Oy and Loisto Laboratoriot Oy, in a transaction financed through debt committed by Terveystalo's existing partner banks. The acquisition is subject to approval by the Finnish Competition and Consumer Authority. The transaction directly supports Terveystalo's stated strategic objective of doubling its oral health business and becoming one of Finland's leading oral health companies, as communicated at its 2024 Capital Markets Day. Significant value creation is expected through growth and cost synergies, anticipated to materialise primarily within 36 months of closing. The transaction is expected to be earnings per share accretive from the first full year following completion.

CIR has signed a binding agreement to acquire the remaining 40.23% stake in KOS Group from F2i Healthcare (controlled by F2i Sgr and its co-investors), moving to 100% ownership. The strategic rationale for the transaction is to consolidate full industrial control over CIR's most strategic asset, enabling simplified governance and a more agile execution of KOS's expansion plans in Italy and Germany. By deploying its available cash reserves, CIR eliminates minority leakage and positions itself to capture the full upside of KOS’s performance recovery. The deal structure includes a potential earn-out based on future performance thresholds and an anti-embarrassment clause valid through mid-2028. This move marks the successful exit of the financial partner after a nine-year investment cycle and reinforces CIR’s long-term commitment to the healthcare infrastructure sector as its primary growth engine.

Groupe Resonance Imagerie, a french medical imaging group supported by Andera Partners for the past three years, is pursuing its geographical consolidation strategy by acquiring the Parisian company Cimep, which brings it 12 centers and nearly EUR20 million in additional revenue. The organization operates as a high-fidelity practitioner-led platform, focusing on the seamless integration of radiology expertise with advanced medical imaging technologies. Rather than focusing solely on basic diagnostics, the firm thrives on a philosophy of technical operational depth, managing a distributed network of centers that provide high-capacity scanning, MRI, and ultrasound services. Its value proposition centers on maintaining a strong medical project led by senior practitioners, ensuring high clinical standards for patients in the Val-de-Marne and Seine-Saint-Denis areas.

Bridgepoint acquired MyDentist from its long-term owners (likely Palamon Capital Partners and The Carlyle Group). Bridgepoint aims to accelerate the group's pivot from low-margin NHS contracts toward high-growth private treatments (implants, aesthetics, clear aligners). Leveraging its prior success with Oasis Dental Care, Bridgepoint plans to implement a rigorous operational efficiency program, utilizing digitalization and AI to optimize chair utilization and patient triage. Furthermore, MyDentist will serve as a consolidation platform, aggressively acquiring smaller independent practices to realize economies of scale in a fragmented market.

Clariane sells its French home hospitalization business to the leader of the sector in France, Fondation Sante Service. The deal is part of Clariane's EUR1bn asset disposal plan to strengthen its balance sheet.

Eurofins Scientific has completed the acquisition of 100% of SYNLAB’s clinical diagnostics operations in Spain. The transaction, initially agreed upon in October 2024, was finalized on March 31, 2025. This strategic carve-out allows SYNLAB to optimize its portfolio by exiting the Spanish market to focus on regions with higher strategic impact. For Eurofins, the acquisition is transformative, merging SYNLAB’s assets with its existing Eurofins Megalab network to become the undisputed leader in clinical diagnostics in Spain. The combined entity now possesses a workforce of over 2,000 employees and the capacity to serve more than 10 million patients annually, processing over 100 million tests. The strategic rationale centers on total geographic coverage of Spain and enhanced capabilities in specialized testing such as genetics. The deal was integrated without significant restructuring due to the complementary nature of the laboratory footprints.

The transaction involves a primary Owner Buy-Out (OBO) where Capza and Bpifrance acquire a minority stake in Imdev to support its next phase of pan-European scaling. This capital injection includes a significant capital increase and a cash-out component for historical shareholders. The strategic rationale is centered on accelerating a nationwide build-up strategy, with a target of 15 to 30 additional acquisitions per year to double the group's size. Financially, the deal is supported by a unitranche debt facility provided by ICG, which was restructured to accommodate the group's new growth ambitions. This platform investment highlights the ongoing institutionalization of the French medical imaging market, where specialized financial sponsors provide the dry powder necessary for heavy equipment modernization and digital transformation, particularly in AI and tele-radiology.

Sonic Healthcare has signed binding agreements to acquire the LADR Laboratory Group, marking a substantial expansion of its German and European diagnostic footprint. The transaction was structured on a cash and debt-free basis, with a total consideration satisfied through a mix of Sonic ordinary shares (up to 222 million euros) and cash funded from existing facilities. The strategic rationale centers on the strong cultural and operational alignment between the two organizations, with significant synergy potential identified in procurement, laboratory overlaps, logistics, and equipment maintenance. The deal also includes an inherited put/call structure for a separate German laboratory business, expected to be fully consolidated by 2027. Following the acquisition, the target's senior leadership, including the CEO and Medical Director, will remain with the group to lead the integration collaboratively with the acquirer’s German division.

Bridgepoint divested its entire stake in Care UK to Welltower, a US healthcare REIT, marking the conclusion of approximately 14 years of private equity ownership. Bridgepoint had originally acquired Care UK in 2010 and had previously attempted an unsuccessful sale process, incurring £2.5 million in abortive advisory costs as disclosed in its 2019 accounts. The deal excludes Practice Plus Group, which was carved out by Bridgepoint in 2019 and remains under its ownership. Bridgepoint was advised by Barclays (corporate finance), Allen & Overy (legal), and EY (financial and tax).